Louisiana hospitals are preparing for a new law categorizing mifepristone and misoprostol as controlled substances, impacting how abortion and miscarriage-related drugs are accessed.
Jennifer Avegno from the New Orleans Health Department expressed concern that the new restrictions, which may add crucial minutes to accessing medication, could pose life-threatening risks for patients in emergencies.
The law categorizes mifepristone and misoprostol alongside addictive substances and threatens severe penalties for unauthorized possession, raising alarms among healthcare providers about patient safety.
Pharmacists continue to struggle with unclear state guidance regarding prescription requirements under the new law, further complicating access to essential medications for severe pregnancy-related complications.
[
Collection
]
[
|
...
]